Your widget preview

Create your own free news widgets.

BD Announces FDA 510(k) Clearance Of BD ProbeTecT Qx Amplified Assays For The Detection Of Chlamydia Trachomatis And Neisseria Gonorrhoeae
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTecT Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTecT Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay on the next-generation BD ViperT System with XTRT Technology.
Medical News Today

FDA approves Symbyax for treatment-resistant depression
The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company has announced.
News Medical

Federal Contract For Restoration Of Damaged Muscle
CellThera, a biotechnology company located in Worcester Polytechnic Institute's Life Sciences and Bioengineering Center at Gateway Park, has received a contract from the U.S. Defense Advanced Research Projects Agency (DARPA) to extend its research program in tissue regeneration.
Medical News Today

Micromet Has Started A New Phase 2 Trial With Adecatumumab In Colorectal Cancer Patients
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced the commencement of a randomized, controlled phase 2 trial of its human anti-EpCAM IgG1 antibody adecatumumab (MT201) for the treatment of patients with colorectal cancer (CRC) after complete resection of liver metastases.
Medical News Today

Data Safety Monitoring Board Unanimously Recommends Continuation Of Delcath Phase III Clinical Trial For Inoperable Metastatic Melanoma
Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary Percutaneous Hepatic Perfusion ('PHP') System(TM) for the treatment of cancers of the liver, announced that the Data and Safety Monitoring Board ('DSMB') reviewed clinical data on the first 51 patients enrolled in the Phase III clinical trial treating metastatic cutaneous and ocular melanoma to the liver.
Medical News Today

FDA Approves Symbyax(R) As First Medication For Treatment-Resistant Depression
The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax(R) (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company (NYSE: LLY) announced. Symbyax is now the first drug approved by the FDA for the acute treatment of treatment-resistant depression (TRD). 'Living with major depressive disorder is difficult and distressing for anyone, but even more so for patients whose symptoms continue despite treatment,' said Lilly Medical Director Dr.
Medical News Today

Phase III Trial Showed Investigational Compound Arzoxifene Was Superior To Evista(R) (raloxifene HCl) In Increasing BMD In Postmenopausal Women
Eli Lilly and Company (NYSE: LLY) presented new data showing arzoxifene, an investigational selective estrogen receptor modulator (SERM), was superior to raloxifene at increasing bone mineral density (BMD) in the lumbar spine, total hip and femoral neck, and at suppressing bone turnover as assessed by serum markers of bone metabolism.
Medical News Today

Foundation Venture Capital Group Invests In UMDNJ Company Working To Improve Leukemia Treatments
Each year in the United States more than 138,000 people are diagnosed with leukemia, lymphoma or myeloma. These new cases account for 10 percent of the new total cancer cases in the U.S. per year. For several types of leukemia, the survival rate has not changed in the past 25 years. That's why James M.
Medical News Today

Updating news archive




Popular search keywords in health:

evidence benefit   restaurants changing   fat ban   food chains   finds researchers   data number   increased men   health election   heart driven   childhood low   factors associated   common fears   june th   researchers virginia   incentives doctors   people think   dementia old   people medicare   during childhood   genetic factors   age genetic   fast food   factors decline   national study   researchers university   cases federal   oral care   medical error   smoking   diabetes   breast   patients   school   product   government   medical device   deaths state   cancer urotodaycom   diabetes insipidus   bisexual men   study published   university faculty   published british   health serv   smoking offering   journal bone   european expand   proposal published   targeted treatment   care treatment  


Archived "health - biotech company" news stories.

Available news archives.

November 2009
S M T W T F S
 1    2    3    4    5    6    7  
 8    9    10    11    12    13    14  
 15    16    17    18    19    20    21  
 22    23    24    25    26    27    28  
 29    30            
             
October 2009
S M T W T F S
         1    2    3  
 4    5    6    7    8    9    10  
 11    12    13    14    15    16    17  
 18    19    20    21    22    23    24  
 25    26    27    28    29    30    31  
             
September 2009
S M T W T F S
     1    2    3    4    5  
 6    7    8    9    10    11    12  
 13    14    15    16    17    18    19  
 20    21    22    23    24    25    26  
 27    28    29    30        
             
August 2009
S M T W T F S
             1  
 2    3    4    5    6    7    8  
 9    10    11    12    13    14    15  
 16    17    18    19    20    21    22  
 23    24    25    26    27    28    29  
 30    31            
July 2009
S M T W T F S
       1    2    3    4  
 5    6    7    8    9    10    11  
 12    13    14    15    16    17    18  
 19    20    21    22    23    24    25  
 26    27    28    29    30    31    
             
June 2009
S M T W T F S
   1    2    3    4    5    6  
 7    8    9    10    11    12    13  
 14    15    16    17    18    19    20  
 21    22    23    24    25    26    27  
 28    29    30          
             
May 2009
S M T W T F S
           1    2  
 3    4    5    6    7    8    9  
 10    11    12    13    14    15    16  
 17    18    19    20    21    22    23  
 24    25    26    27    28    29    30  
 31              
April 2009
S M T W T F S
       1    2    3    4  
 5    6    7    8    9    10    11  
 12    13    14    15    16    17    18  
 19    20    21    22    23    24    25  
 26    27    28    29    30      
             
March 2009
S M T W T F S
 1    2    3    4    5    6    7  
 8    9    10    11    12    13    14  
 15    16    17    18    19    20    21  
 22    23    24    25    26    27    28  
 29    30    31          
             
February 2009
S M T W T F S
 1    2    3    4    5    6    7  
 8    9    10    11    12    13    14  
 15    16    17    18    19    20    21  
 22    23    24    25    26    27    28  
             
             
January 2009
S M T W T F S
         1    2    3  
 4    5    6    7    8    9    10  
 11    12    13    14    15    16    17  
 18    19    20    21    22    23    24  
 25    26    27    28    29    30    31  
             
December 2008
S M T W T F S
   1    2    3    4    5    6  
 7    8    9    10    11    12    13  
 14    15    16    17    18    19    20  
 21    22    23    24    25    26    27  
 28    29    30    31        
             

How does Feedzilla work?

Feedzilla is a news aggregator which categorizes news stories by topic. It is a platform where webmasters and bloggers can find an unmatched selection of easy to use, automatically updating and professional news widgets for their sites. Feedzilla supports the building of widgets in various formats, as well as allowing the addition of news widgets to different blogging platforms and social networks.

Feedzilla manually aggregates news summaries found in RSS feeds, and redistributes them in either RSS format or as a news widget. Content is collected 24 hours a day, 7 days a week from an ever-growing list of providers.

Hot keywords

afghan borderair franceairlines jetalmost investigatorsany evidencearmy takesarrive iranatlantic cityauthorities seekingavoid toxicballoon boybarack obamabillowing fireblaze windburning fuelstoragecairo egyptcancer screeningcaptured hometowncar bombschatham boroughchurch janitorcity qomclaiming memoryclaims memorycnn viewercollide egyptcollided outsidecomplex puertocountrys interiordeath tolldeclares swinedied trainsdisclosed nucleared hindsegypt officialsemergency presidentemergency whiteensure usedeven ownexpect deathfacility cityfacility internationalfamily homefears growfight precededflu nationalfound nyfound slainfridays earthshakingfuel storagefuelstorage sitegermanys coalitiongirl foundhealth riskhn swinehome evenhometown pakistanihugo chidentified youngidentifying teenagerinspect newlyinspect nuclearinterior ministryinternational officialsiran inspectjanitor chargedkilling peoplelead killerliving outskirtsmanhattan claimingmemory homememory namemurdered almostname familynational emergencynatoled troopsnewly disclosednorthwest airlinesnuclear facilitynuclear siteny claimsobama declaresofficials arriveofficials expectoutside cairooutskirts burningown namepeaceful purposespeople diedpeople evacuatedpeople livingpolice cnnpolice policepolygamist sectpresident barackpriest foundprime ministerpublics identifyingpuerto ricoqom ensureraging firerelocate avoidresidents riskrev edrico firerico officialsrico urgedrise countrysrisk fuelseeking publicsshift putshrimp vesselsite puertosite urgedsmall townsmoke inhalationsmoke stillstill billowingstronghold alongswine flutaliban chieftaliban chiefsteenager turnedtoll risetoxic smoketrains collidedtroops seizeturned manhattanun inspectorsurged relocateused peacefulvenezuelan presidentviewer identifiedwar crimeswarns healthwhite housewoman turnedyoung woman

News poll

Press release

9th of September 2009 - Interview of Feedzilla's founder at the IFA in Berlin. [More]

Testimonials

Feedzilla is the best news feeds provider around! I love their services!
Allan Andrews